# FDA Inspection 801722 - Milhem, Dr Mohammed - September 26, 2012

Source: https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/24afee48-635a-4f32-99f5-96ae5216dc89
Source feed: FDA_Inspections

> FDA Inspection 801722 for Milhem, Dr Mohammed on September 26, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 801722
- Company Name: Milhem, Dr Mohammed
- Inspection Date: 2012-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267638 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/11ae809d-9328-4dbd-bf29-d27c114c5661)
- [FDA Inspection 1267638 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/1101142f-2e48-42a3-b030-d5ed969597c0)
- [FDA Inspection 910676 - 2015-01-08](https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/19c3a667-b903-4af6-8394-2d8fc10e6891)

Company: https://www.keypedia.com/companies/milhem-dr-mohammed/02e6cb37-1997-4f4a-9941-d1cd67b53632

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c